by Reuters Health, Last updated April 04, 2012
(Reuters) - The Food and Drug Administration issued a recall Wednesday of Thoratec Corp's HeartMate II pump after it was found that a key part of the surgical procedure was omitted from the instructions, which could lead to serious side effects or even death.
Analysts said, however, that the recall does mean the product will have to be removed from the shelves and Thoratec does not have to halt marketing the product.
The announcement was posted by the FDA on its website.
The FDA described the action as a Class I recall, the most serious type, and said clinicians have been instructed to follow the revised instructions for use, which "clarify the recommended procedure for securing the bend relief to the outflow graft."
If the two parts of the device are not secured correctly, the FDA said, the product may cause serious health consequences, including death. A new caution statement regarding the connection is included in the new label.
Thoratec was not immediately available for comment.
by Jennifer Newell, Last updated February 14, 2013
by Madeline Ellis, Last updated February 07, 2013
by Alister Doyle, Last updated January 10, 2013
by Kathryn Doyle , Last updated January 10, 2013
by Genevra Pittman, Last updated January 08, 2013
The content provided in this site is strictly for you to be able to find helpful information on improving your life and health. None of the information here is to be construed as medical advice. Only your own doctor who has examined you can give you medical advice. None of the authors of any content in this website, even if the author is a licensed physician, are providing you with medical advice through this website. Please review any news or information you see on this website with your own physician in order to obtain actual medical advice.
© 2013 HealthNews, Inc. All Rights Reserved EN-US
